Elevated proto-oncogene and collagen mRNA expression in PVR retinas

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 241, Issue 5, 2003, Pages 439-446

  Hollborn, Margrit ^a   Faude, Frank ^a   Wiedemann, Peter ^a   Kohen, Leon ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 3; COLLAGEN TYPE 4; KI 67 ANTIGEN; MYC PROTEIN; PROTEIN C FOS; STRUCTURAL PROTEIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA TRANSPLANTATION; DONOR; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; MEMBRANE FORMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTO ONCOGENE; RETINA DETACHMENT; RETINA DETACHMENT SURGERY; RIBONUCLEASE PROTECTION ASSAY; UPREGULATION; VITREORETINOPATHY;

EID: 0038000570     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-003-0664-2     Document Type: Article

References (55)

1. Agata K, Kobayashi H, Itoh Y, Mochii M, Sawada K, Eguchi G (1993) Genetic characterization of the multipotent dedifferentiated state of pigmented epithelial cells in vitro. Development 118:1025-1030
2. Ando A, Ueda M, Uyama M, Masu Y, Ito S (2000) Enhancement of dedifferentiation and myoid differentiation of retinal pigment epithelial cells by platelet derived growth factor. Br J Ophthalmol 84:1306-1311
3. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim.Biophys Acta 1072:129-157
4. Beche-Belsot JS, Planque N, Martin P, Saule S (2001) [The myc oncogene and transdifferentiation of the retinal pigment epithelium]. J Soc.Biol 195:107-113
5. Bringmann A, Francke M, Pannicke T, Biedermann B, Faude F, Enzmann V, Wiedemann P, Reichelt W, Reichenbach A (1999) Human Muller glial cells: altered potassium channel activity in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 40:3316-3323
6. Bustin SA, Nie XF, Barnard RC, Kumar V, Pascall JC, Brown KD, Leigh IM, Williams NS, McKay IA (1994) Cloning and characterization of ERF-1, a human member of the Tis11 family of early-response genes. DNA Cell Biol 13:449-459
7. Campochiaro P (1997) Pathogenic mechanisms in proliferative vitreoretinopathy. Arch Ophthalmol 115:237-241
8. Capeans C, Pineiro A, Dominguez F, Loidi L, Buceta M, Carneiro C, Garcia-Caballero T, Sanchez-Salorio M (1998) A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation. Exp Eye Res 66:581-589
9. Casaroli-Marano RP, Vilaro S (1994) The role of fibronectin, laminin, vitronectin and their receptors on cellular adhesion in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35:2791-2803
10. Casaroli-Marano RP, Pagan R, Vilaro S (1999) Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 40:2062-2072
11. Chirila TV, Thompson-Wallis DE, Crawford GJ, Constable IJ, Vijayasekaran S (1996) Production of neocollagen by cells invading hydrogel sponges implanted in the rabbit cornea. Graefes Arch Clin Exp Ophthalmol 234:193-198
12. Curran T, Bravo R, Muller R (1985) Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation. Cancer Surv 4:655-681
13. DePinho RA, Schreiber-Agus N, Alt FW (1991) myc family oncogenes in the development of normal and neoplastic cells. Adv Cancer Res 57:1-46
14. El-Ghrably IA, Dua HS, Orr GM, Fischer D, Tighe PJ (2001) Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol 85:461-470
15. Esser P, Weller M, Heimann K, Wiedemann P (1991) [Thrombospondin and its importance in proliferative retinal diseases]. Fortschr Ophthalmol 88:337-340
16. Funato T, Ishii T, Kanbe M, Scanlon KJ, Sasaki T (1997) Reversal of cisplatin resistance in vivo by an antifos ribozyme. In Vivo 11:217-220
17. Geller SF, Lewis GP, Fisher SK (2001) FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Muller and RPE cells. Invest Ophthalmol. Vis Sci 42:1363-1369
18. Girard P, Mimoun G, Karpouzas I, Montefiore G (1994) Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 14:417-424
19. Gonzalez-Avila G, Lozano D, Manjarrez ME, Ruiz VM, Teran L, Vadillo-Ortega F, Selman M (1995) Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy. Ophthalmology 102:1400-1405
20. Guerin CJ, Hu L, Scicli G, Scicli AG (2001) Transforming growth factor beta in experimentally detached retina and periretinal membranes. Exp Eye Res 73:753-764
21. Harris LL, Talian JC, Zelenka PS (1992) Contrasting patterns of c-myc and N-myc expression in proliferating, quiescent, and differentiating cells of the embryonic chicken lens. Development 115:813-820
22. Heidenkummer HP, Kampik A (1991) [Comparative immunohistochemical studies of epiretinal membranes in proliferative vitreoretinal diseases]. Fortschr Ophthalmol 88:219-224
23. Heidenkummer HP, Kampik A, Petrovski B (1992) Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases. Retina 12:52-58
24. Hinton DR, He S, Jin ML, Barron E, Ryan SJ (2002) Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy. Eye 16:422-428
25. Ikuno Y, Kazlauskas A (2002) TGFbeta1-dependent contraction of fibroblasts is mediated by the PDGFalpha receptor. Invest Ophthalmol Vis Sci 43:41-46
26. Jerdan JA, Pepose JS, Michels RG, Hayashi H, de Bustros S, Sebag M, Glaser BM (1989) Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 96:801-810
27. Kamei M, Kawasaki A, Tano Y (1998) Analysis of extracellular matrix synthesis during wound healing of retinal pigment epithelial cells. Microsc Res Tech 42:311-316
28. Kon CH, Asaria RH, Occleston NL, Khaw PT, Aylward GW (2000) Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study. Br.J Ophthalmol 84:506-511
29. Lee SC, Kim SH, Koh HJ, Kwon OW (2001) TGF-betas synthesized by RPE cells have autocrine activity on mesenchymal transformation and cell proliferation. Yonsei Med J 42:271-277
30. Lee SC, Kwon OW, Seong GJ, Kim SH, Ahn JE, Kay ED (2001) Epithelio-mesenchymal transdifferentiation of cultured RPE cells. Ophthalmic Res 33:80-86
31. Lewis GP, Fisher SK (2000) Muller cell outgrowth after retinal detachment: association with cone photoreceptors. Invest Ophthalmol Vis Sci 41:1542-1545
32. Li DW, Spector A (1997) Hydrogen peroxide-induced expression of the protooncogenes, c-jun, c- fos and c-myc in rabbit lens epithelial cells. Mol Cell Biochem 173:59-69
33. Machemer R, van Horn D, Aaberg TM (1978) Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 85:181-191
34. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM (1991) An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 112:159-165
35. Mandava N, Blackburn P, Wilson M, Paul D, Alspaugh E, Whiting C, Barber J, Robbins J, Broswick B, Kruse C (2000) Chimeric ribozyme to proliferating cell nuclear antigen (PCNA) prevents retinal detachment (RD) in a model of proliferative vitreoretinopathy (PVR). Invest Ophthalmol Vis Sci 41:S542
36. Mitamura Y, Takeuchi S, Yamamoto S, Yamamoto T, Tsukahara I, Matsuda A, Tagawa Y, Mizue Y, Nishihira J (2002) Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy. Jpn J Ophthalmol 46:218-221
37. Morgenbesser SD, Schreiber-Agus N, Bidder M, Mahon KA, Overbeek PA, Horner J, DePinho RA (1995) Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J 14:743-756
38. Morita Y, Kashihara N, Yamamura M, Okamoto H, Harada S, Kawashima M, Makino H (1998) Antisense oligonucleotides targeting c-fos mRNA inhibit rheumatoid synovial fibroblast proliferation. Ann Rheum Dis 57:122-124
39. Nath P, Getzenberg R, Beebe D, Pallansch L, Zelenka P (1987) c-myc mRNA is elevated as differentiating lens cells withdraw from the cell cycle. Exp Cell Res 169:215-222
40. Potter JJ, Rennie-Tankersley L, Anania FA, Mezey E (1999) A transient increase in c-myc precedes the transdifferentiation of hepatic stellate cells to myofibroblast-like cells. Liver 19:135-144
41. Rao GN, Church RL (1989) Regulation of expression of c-myc protoocogene in a clonal line of mouse lens epithelial cells by serum growth factors. Exp Cell Res 183:140-148
42. Ren G, Fuse N, Abe T, Tamai M (2000) mRNA expression of proto-oncogenes and platelet-derived growth factor in proliferative vitreoretinal diseases. Jpn J Ophthalmol 44:308-311
43. Rosenfeldt H, Lee DJ, Grinnell F (1998) Increased c-fos mRNA expression by human fibroblasts contracting stressed collagen matrices. Mol Cell Biol 18:2659-2667
44. Ryan SJ (1993) Traction retinal detachment. XLIX Edward Jackson Memorial Lecture. Am J Ophthalmol 115:1-20
45. Santoro C, Mermod N, Andrews PC, Tjian R (1988) A family of human CCAAT-box-binding proteins active in transcription and DNA replication: cloning and expression of multiple cDNAs. Nature 334:218-224
46. Scott JL, Dunn SM, Zeng T, Baker E, Sutherland GR, Burns GF (1994) Phorbol ester-induced transcription of an immediate-early response gene by human T cells is inhibited by cotreatment with calcium ionophore. J Cell Biochem 54:135-144
47. Shi Y, Hui Y, Ma J (1996) An immunohistochemical study of IgG, complement C3, collagen type III and macrophage-marker Ki-M7 in epiretinal membranes. Yan Ke Xue Bao 12:10-14
48. Wagner EF (2001) AP-1. Introductory remarks. Oncogene 20:2334-2335
49. Weller M, Heimann K, Wiedemann P (1989) Immunochemical analysis of periretinal membranes: review and outlook. In: Straub W (ed) Developments in ophthalmology, vol 16. Karger, Basel, pp 54-74
50. Weller M, Wiedemann P, Heimann K (1990) Proliferative vitreoretinopathy - is it anything more than wound healing at the wrong place? Int Ophthalmol 14:105-117
51. Wiedemann P (1992) Growth factors in retinal diseases: proliferative vitreoretinopathy, proliferative diabetic retinopathy and retinal degeneration. Surv Ophthalmol 36:373-384
52. Wiedemann P, Weller M (1988) The pathophysiology of proliferative vitreoretinopathy. Acta Ophthalmol 66:7-15
53. Wiedemann P, Weller M, Heimann K (1990) [Proliferative vitreoretinopathy: new discoveries in pathophysiology and therapy]. Klin Monatsbl Augenheilkd 197:355-361
54. Yoshida K, Muraki Y, Ohki K, Harada T, Ohashi T, Matsuda H, Imaki J (1995) C-fos gene expression in rat retinal cells after focal retinal injury. Invest Ophthalmol Vis Sci 36:251-254
55. Zhang Y, Feng XH, Derynck R (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394:909-913